Biogen seeking more information in investigation of Aduhelm patient's death

Biogen is seeking brain imaging results as part of an investigation into the death of a 75-year-old woman who was taking the company's Alzheimer's disease drug Aduhelm, but has not yet established the cause of her passing and whether its drug was a factor.